Literature DB >> 18605076

Soluble Fc fusion proteins for biomedical research.

Meg L Flanagan1, Robyn S Arias, Peisheng Hu, Leslie A Khawli, Alan L Epstein.   

Abstract

As a source of recombinant antigen, soluble constant fragment (Fc) fusion proteins have become valuable reagents for immunotherapy and laboratory investigations. Additional applications for these reagents include flow cytometry, immunohistochemistry, and in vitro activity assays. To aid investigators in the generation of these reagents, the materials and methods required for producing Fc fusion proteins are described. The investigator's protein moiety of interest is genetically linked to the N-terminus of murine Fc and subsequently expressed in large quantity using a mammalian cell expression system. The resulting Fc fusion proteins are purified on a protein A column and may be stored for at least one year at -20 degrees C. The availability of easily purified, soluble Fc fusion proteins in such quantity can facilitate research in multiple fields of medicine and biotechnology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18605076     DOI: 10.1007/978-1-59745-323-3_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.

Authors:  Tianlei Ying; Weizao Chen; Yang Feng; Yanping Wang; Rui Gong; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

2.  Soluble monomeric IgG1 Fc.

Authors:  Tianlei Ying; Weizao Chen; Rui Gong; Yang Feng; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

3.  Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants.

Authors:  Zhe Lu; Kyung-Jin Lee; Yingxue Shao; Jeong-Hwan Lee; Yangkang So; Young-Kug Choo; Doo-Byoung Oh; Kyung-A Hwang; Seung Han Oh; Yeon Soo Han; Kisung Ko
Journal:  J Biomed Biotechnol       Date:  2012-05-23

4.  Effect of the developmental stage and tissue position on the expression and glycosylation of recombinant glycoprotein GA733-FcK in transgenic plants.

Authors:  Chae-Yeon Lim; Kyung Jin Lee; Doo-Byoung Oh; Kisung Ko
Journal:  Front Plant Sci       Date:  2015-01-13       Impact factor: 5.753

5.  Incorporation of native antibodies and Fc-fusion proteins on DNA nanostructures via a modular conjugation strategy.

Authors:  Bas J H M Rosier; Glenn A O Cremers; Wouter Engelen; Maarten Merkx; Luc Brunsveld; Tom F A de Greef
Journal:  Chem Commun (Camb)       Date:  2017-06-29       Impact factor: 6.222

6.  A Supramolecular Platform for the Introduction of Fc-Fusion Bioactive Proteins on Biomaterial Surfaces.

Authors:  Matilde Putti; Simone M J de Jong; Oscar M J A Stassen; Cecilia M Sahlgren; Patricia Y W Dankers
Journal:  ACS Appl Polym Mater       Date:  2019-06-13

Review 7.  Fc-fusion proteins: new developments and future perspectives.

Authors:  Daniel M Czajkowsky; Jun Hu; Zhifeng Shao; Richard J Pleass
Journal:  EMBO Mol Med       Date:  2012-07-26       Impact factor: 12.137

8.  Construction and Production of Foxp3-Fc (IgG) DNA Vaccine/Fusion Protein.

Authors:  Neda Mousavi Niri; Arash Memarnejadian; Jamshid Hadjati; Mohammad Reza Aghasadeghi; Mehdi Shokri; Yones Pilehvar-Soltanahmadi; Abolfazl Akbarzadeh; Nosratollah Zarghami
Journal:  Avicenna J Med Biotechnol       Date:  2016 Apr-Jun

9.  Three Recombinant Engineered Antibodies against Recombinant Tags with High Affinity and Specificity.

Authors:  Hongyu Zhao; Ao Shen; Yang K Xiang; David P Corey
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

10.  Multi-Compartment and Multi-Host Vector Suite for Recombinant Protein Expression and Purification.

Authors:  Claudia Ortega; Daniel Prieto; Cecilia Abreu; Pablo Oppezzo; Agustín Correa
Journal:  Front Microbiol       Date:  2018-06-27       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.